Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.

Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.

OBJECTIVE: To define the cardiovascular effects of lowering blood pressure in people with chronic kidney disease. DESIGN: Collaborative prospective meta-analysis of randomised trials. DATA SOURCES AND ELIGIBILITY: Participating randomised trials of drugs to lower blood pressure compared with placebo...

Descripció completa

Dades bibliogràfiques
Autors principals:	Ninomiya, T, Perkovic, V, Turnbull, F, Neal, B, Barzi, F, Cass, A, Baigent, C, Chalmers, J, Li, N, Woodward, M, MacMahon, S
Format:	Journal article
Idioma:	English
Publicat:	2013

Ítems similars

Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials.
per: Turnbull, F, et al.
Publicat: (2008)

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
per: Czernichow, S, et al.
Publicat: (2011)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
per: Lv, J, et al.
Publicat: (2012)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis.
per: Jicheng Lv, et al.
Publicat: (2012-01-01)

Lower blood pressure and risk of recurrent stroke in patients with chronic kidney disease: PROGRESS trial
per: Ninomiya, T, et al.
Publicat: (2008)

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.
per: Sundström, J, et al.
Publicat: (2014)

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
per: Arima, H, et al.
Publicat: (2010)

High prevalence of chronic kidney disease in Thailand
per: Perkovic, V, et al.
Publicat: (2008)

Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial
per: Arima, H, et al.
Publicat: (2011)

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
per: Turnbull, F
Publicat: (2003)

Lowering blood pressure reduces renal events in type 2 diabetes.
per: de Galan, B, et al.
Publicat: (2009)

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
per: Neal, B, et al.
Publicat: (2000)

The Framingham Study, Diabetes Mellitus and Cardiovascular Disease: Turning Back the Clock
per: Kengne, A, et al.
Publicat: (2010)

Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial.
per: Berthet, K, et al.
Publicat: (2004)

Blood Pressure and Cardiovascular Disease: Tracing the Steps From Framingham
per: Turnbull, F, et al.
Publicat: (2010)

Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
per: Arima, H, et al.
Publicat: (2010)

Blood pressure lowering and cardiovascular risk - Authors' reply.
per: Sundström, J, et al.
Publicat: (2014)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
per: Zoungas, S, et al.
Publicat: (2009)

Severe Hypoglycemia and Risks of Vascular Events and Death
per: Zoungas, S, et al.
Publicat: (2010)

Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.
per: Turnbull, F, et al.
Publicat: (2007)

Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease.
per: Campbell, D, et al.
Publicat: (2007)

Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial.
per: Arima, H, et al.
Publicat: (2012)

Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes - authors' reply
per: Nazarzadeh, M, et al.
Publicat: (2022)

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.
per: Collins, R, et al.
Publicat: (2001)

Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies.
per: MacMahon, S, et al.
Publicat: (2001)

The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture
per: Prentice, C, et al.
Publicat: (1999)

Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: a systematic review of randomized trials
per: Salam, A, et al.
Publicat: (2018)

Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors.
per: MacMahon, S, et al.
Publicat: (1997)

Associations of proinflammatory cytokines with the risk of recurrent stroke.
per: Welsh, P, et al.
Publicat: (2008)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
per: Hata, J, et al.
Publicat: (2012)

Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China
per: Wu, Y, et al.
Publicat: (2016)

Blood Pressure Is a Major Risk Factor for Renal Death: An Analysis of 560 352 Participants From the Asia-Pacific Region
per: O'Seaghdha, C, et al.
Publicat: (2009)

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.
per: Yusuf, S, et al.
Publicat: (1988)

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.
per: Collins, R, et al.
Publicat: (1996)

Ten-year predictors of major adverse cardiovascular events in patients without angina
per: Preesha Premsagar, et al.
Publicat: (2023-08-01)

Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trial.
per: Jun Hata, et al.
Publicat: (2013-01-01)

Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease.
per: Campbell, D, et al.
Publicat: (2007)

Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
per: Campbell, D, et al.
Publicat: (2006)

Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
per: Campbell, D, et al.
Publicat: (2005)

Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
per: Campbell, D, et al.
Publicat: (2005)